Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anticholinergic and membrane activities of amantadine in neuromuscular transmission.

× No keyword cloud information.

11 in total

Review 1. Current drug therapy for Parkinson's disease. A review.

Authors: R J Coleman
Journal: Drugs Aging Date: 1992 Mar-Apr Impact factor: 3.923

2. Forskolin blocks carbachol-mediated ion-permeability of chick myotube nicotinic receptors and inhibits binding of 3H-phencyclidine to Torpedo microsac nicotinic receptors.

Authors: J Häggblad; H Eriksson; B Hedlund; E Heilbronn
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1987-10 Impact factor: 3.000

Review 3. Clinical pharmacokinetics of anti-parkinsonian drugs.

Authors: J M Cedarbaum
Journal: Clin Pharmacokinet Date: 1987-09 Impact factor: 6.447

Review 4. Novel approaches to the treatment of cocaine addiction.

Authors: Mehmet Sofuoglu; Thomas R Kosten
Journal: CNS Drugs Date: 2005 Impact factor: 5.749

Review 5. A risk-benefit assessment of drugs used in the management of Parkinson's disease.

Authors: I Y Bodagh; D R Robertson
Journal: Drug Saf Date: 1994-08 Impact factor: 5.606

Review 6. Antiparkinsonian agents. Drug interactions of clinical significance.

Authors: R F Pfeiffer
Journal: Drug Saf Date: 1996-05 Impact factor: 5.606

7. Antiparkinsonian Agents : Clinically Significant Drug Interactions and Adverse Effects, and Their Management.

Authors: A Dalvi; B Ford
Journal: CNS Drugs Date: 1998-04 Impact factor: 5.749

8. Amantadine antagonism of oxotremorine effects.

Authors: Y Eshel; A D Korczyn
Journal: J Neural Transm Date: 1979 Impact factor: 3.575

Review 9. Anti-parkinsonian drugs today.

Authors: N P Quinn
Journal: Drugs Date: 1984-09 Impact factor: 9.546

Review 10. Neuroprotective strategies in Parkinson's disease : an update on progress.

Authors: Silvia Mandel; Edna Grünblatt; Peter Riederer; Manfred Gerlach; Yona Levites; Moussa B H Youdim
Journal: CNS Drugs Date: 2003 Impact factor: 5.749